CS

Chimata Sandeep

Active Director Designated Partner DIN 10203199
DIN 10203199 First appointment Jun 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Chimata Sandeep

Data last updated:

Chimata Sandeep is a Designated Partner at Prime Care Super Speciality Hospital Llp (since 2023). The company operates in Healthcare.

DIN 10203199
Primary Designation Designated Partner
Industry Healthcare
First Appointment 13 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Jun 20232023Active

Board colleagues of Chimata Sandeep

Directorship timeline

Open interactive timeline →
Prime Care Super Speciality Hospital Llp
Premium access

Shareholding and investment profile for Chimata Sandeep

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chimata Sandeep

Chimata Sandeep currently holds 1 directorship: Prime Care Super Speciality Hospital Llp (Designated Partner, since 13 Jun 2023).

Chimata Sandeep was first appointed on 13 Jun 2023 as Designated Partner at Prime Care Super Speciality Hospital Llp.

The current boards of Chimata Sandeep's companies include Gangadhara Nellore Suresh Babu (Prime Care Super Speciality Hospital Llp), Mahaboob Pasha Shaik (Prime Care Super Speciality Hospital Llp), Vasanthalakshmi Devi Chavva (Prime Care Super Speciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available